PDB16 A POPULATION-ADJUSTED INDIRECT COMPARISON OF CARDIOVASCULAR BENEFITS BETWEEN ONCE-WEEKLY SEMAGLUTIDE AND DULAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES AND HIGH CARDIOVASCULAR RISK
May 1, 2020, 00:00
10.1016/j.jval.2020.04.204
https://www.valueinhealthjournal.com/article/S1098-3015(20)30392-2/fulltext
Title :
PDB16 A POPULATION-ADJUSTED INDIRECT COMPARISON OF CARDIOVASCULAR BENEFITS BETWEEN ONCE-WEEKLY SEMAGLUTIDE AND DULAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES AND HIGH CARDIOVASCULAR RISK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30392-2&doi=10.1016/j.jval.2020.04.204
First page :
Section Title :
Open access? :
No
Section Order :
10059